HIGHLIGHTS
- who: Qunfang Ge and colleagues from the Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang, China have published the research: Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration, in the Journal: Evidence-Based Complementary and Alternative Medicine of 11/07/2022
- what: This study systematically analyzed the differences in side effects due to the two modes of administration, as well as the incidence of secondary gastrointestinal bleeding after melphalan pretreatment and the contributing factors.
SUMMARY
High-dose melphalan . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.